IP Library › Assignment 039249/0809
Patent Assignment
Reel/Frame 039249/0809

Assignment of Assignor's Interest

Recorded: 2016-07-26 Pages: 4
Assignor
GLAXOSMITHKLINE
Executed: 2015-03-02
Assignee
NOVARTIS PHARMA AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (9)
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Application: 13/146,493 →
Publication: US 2011/0288142
Combination
Application: 13/699,103 →
Publication: US 2013/0237554
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Application: 14/083,617 →
Publication: US 2014/0073679
Antibody Formulations
Application: 60/948,220 →
Combination
Application: 61/346,992 →
Combination
Application: 61/348,385 →
Methods of Treating Cancer
Application: 61/422,715 →
Combination
Application: 61/431,508 →
Combination
Application: 61/716,790 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 15, 2010
From: GILMER, TONA M.; KUMAR, RAKESH
To: GLAXOSMITHKLINE LLC
Reel/Frame 024987/0908 →
Assignment of Assignor's Interest Sep 15, 2010
From: KUMAR, RAKESH
To: GLAXOSMITHKLINE LLC
Reel/Frame 024987/0967 →
Assignment of Assignor's Interest Nov 21, 2013
From: CHEN, PINGYUN Y.; GAULDING, JEFFREY
To: GLAXOSMITHKLINE LLC
Reel/Frame 031648/0713 →
Assignment of Assignor's Interest Jul 26, 2016
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 039462/0247 →